title: Regulation of endothelial-specific transgene expression by the LacI repressor protein in vivo.
abstract: Genetically modified mice have played an important part in elucidating gene function in vivo. However, conclusions from transgenic studies may be compromised by complications arising from the site of transgene integration into the genome and, in inducible systems, the non-innocuous nature of inducer molecules. The aim of the present study was to use the vascular system to validate a technique based on the bacterial lac operon system, in which transgene expression can be repressed and de-repressed by an innocuous lactose analogue, IPTG. We have modified an endothelium specific promoter (TIE2) with synthetic LacO sequences and made transgenic mouse lines with this modified promoter driving expression of mutant forms of connexin40 and an independently translated reporter, EGFP. We show that tissue specificity of this modified promoter is retained in the vasculature of transgenic mice in spite of the presence of LacO sequences, and that transgene expression is uniform throughout the endothelium of a range of adult systemic and cerebral arteries and arterioles. Moreover, transgene expression can be consistently down-regulated by crossing the transgenic mice with mice expressing an inhibitor protein LacI(R), and in one transgenic line, transgene expression could be de-repressed rapidly by the innocuous inducer, IPTG. We conclude that the modified bacterial lac operon system can be used successfully to validate transgenic phenotypes through a simple breeding schedule with mice homozygous for the LacI(R) protein.
authors.affiliation: Blood Vessel Laboratory, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia; Stem Cell & Gene Targeting Laboratory, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
authors.forename: Susan K
authors.initials: SK
authors.lastname: Morton
authors.affiliation: Blood Vessel Laboratory, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia; Stem Cell & Gene Targeting Laboratory, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Chaston
authors.affiliation: Blood Vessel Laboratory, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
authors.forename: Brett K
authors.initials: BK
authors.lastname: Baillie
authors.affiliation: Blood Vessel Laboratory, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
authors.forename: Caryl E
authors.initials: CE
authors.lastname: Hill
authors.affiliation: Stem Cell & Gene Targeting Laboratory, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
authors.forename: Klaus I
authors.initials: KI
authors.lastname: Matthaei
mesh_terms: D000818:Animals; D017630:Connexins / Q000096:biosynthesis / Q000235:genetics; D042783:Endothelial Cells / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000166:cytology; D015870:Gene Expression; D049452:Green Fluorescent Proteins / Q000096:biosynthesis / Q000235:genetics; D006720:Homozygote; D056968:Lac Repressors / Q000502:physiology*; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009928:Organ Specificity; D011401:Promoter Regions, Genetic; D042787:Receptor, TIE-2 / Q000235:genetics; D015533:Transcriptional Activation; D019076:Transgenes; D000097003:Gap Junction alpha-5 Protein
chemical_list: D017630:Connexins; D049452:Green Fluorescent Proteins; D056968:Lac Repressors; D042787:Receptor, TIE-2; D000097003:Gap Junction alpha-5 Protein; C485184:enhanced green fluorescent protein; C079086:Tek protein, mouse
references.citation: Genesis. 2001 May;30(1):36-44
references.pmid: 11353516
references.citation: Med Res Rev. 2001 Jan;21(1):1-60
references.pmid: 11135298
references.citation: Semin Cell Dev Biol. 2002 Apr;13(2):109-19
references.pmid: 12127144
references.citation: Genes Dev. 2001 Jun 15;15(12):1506-17
references.pmid: 11410531
references.citation: Eur J Biochem. 2001 Mar;268(5):1468-76
references.pmid: 11231300
references.citation: Vascul Pharmacol. 2011 Jul-Sep;55(1-3):17-25
references.pmid: 21742056
references.citation: Obes Res. 2005 Jul;13(7):1146-56
references.pmid: 16076983
references.citation: Mol Imaging. 2004 Jan;3(1):33-42
references.pmid: 15142410
references.citation: PLoS One. 2011 Mar 21;6(3):e18051
references.pmid: 21445314
references.citation: Behav Genet. 2002 Nov;32(6):435-43
references.pmid: 12467341
references.citation: Nat Genet. 1998 Jan;18(1):56-9
references.pmid: 9425901
references.citation: Arterioscler Thromb Vasc Biol. 2013 May;33(5):962-70
references.pmid: 23471232
references.citation: Neuron. 2000 Oct;28(1):41-51
references.pmid: 11086982
references.citation: Dev Biol. 2001 Feb 15;230(2):230-42
references.pmid: 11161575
references.citation: J Cell Sci. 2003 Jun 1;116(Pt 11):2223-36
references.pmid: 12697838
references.citation: J Neurosci. 2003 Dec 17;23(37):11692-7
references.pmid: 14684871
references.citation: J Physiol. 2007 Jul 15;582(Pt 2):481-8
references.pmid: 17495035
references.citation: Annu Rev Genet. 1986;20:465-99
references.pmid: 3545063
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3058-63
references.pmid: 9096345
references.citation: Bioessays. 1998 Jul;20(7):532-5
references.pmid: 9723001